PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS
Toby Eyre,
Nicolas Martinez-Calle,
Renata Walewska,
Joe Hickey,
Betina Blak,
Anna Pickin,
Sukhjit Hunjan,
Orlaith Condon,
Satoshi Hori
Affiliations
Toby Eyre
1 Oxford University Hospitals NHS Foundation Trust, Department of Clinical Haematology, Oxford, United Kingdom
Nicolas Martinez-Calle
2 Nottingham University Hospitals NHS Trust, Clinical Haematology, Nottingham, United Kingdom
Renata Walewska
3 University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom
